SCHEMBL2182372

SCHEMBL2182372

CC1CCc2c(sc(NC(=O)c3ccccc3)c2C(N)=O)C1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.80
PDE4B Q07343 3/20 0.72
TNF P01375 2/20 0.69
NOD1 Q9Y239 2/20 0.69
L3MBTL1 Q9Y468 1/20 0.69
PDE4D Q08499 2/20 0.68
NPC1 O15118 4/20 0.67
RAB9A P51151 4/20 0.67
KMT2A Q03164 4/20 0.67
MEN1 O00255 3/20 0.67
FLT3 P36888 1/20 0.67
CASP3 P42574 1/20 0.67
SENP7 Q9BQF6 1/20 0.67
MAPT P10636 5/20 0.66
DUSP3 P51452 1/20 0.66
PTPN5 P54829 1/20 0.66
PTPN11 Q06124 1/20 0.66
ALDH1A1 P00352 2/20 0.64
KDM4E B2RXH2 2/20 0.64
THRB P10828 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8289821 0.89 MAPT (0.76) TP53PDE4BTNFNOD1L3MBTL1
SCHEMBL21347432 0.87 RAB9A (0.78) TP53PDE4BTNFNOD1L3MBTL1
SCHEMBL22789485 0.85 KMT2A (0.85) TP53PDE4BTNFNOD1L3MBTL1
SCHEMBL21346818 0.85 FLT3 (0.70) TP53PDE4BTNFNOD1L3MBTL1
SCHEMBL28650118 0.84 TP53 (0.72) TP53TNFNOD1KMT2AMEN1
SCHEMBL3922433 0.84 MEN1 (0.82) TP53PDE4BL3MBTL1PDE4DNPC1
SCHEMBL5455162 0.84 MAPT (0.72) TP53PDE4BL3MBTL1PDE4DNPC1
SCHEMBL3914076 0.82 MAPT (0.73) TP53PDE4BL3MBTL1PDE4DNPC1
SCHEMBL3916246 0.82 MAPT (0.78) TP53PDE4BL3MBTL1PDE4DNPC1
SCHEMBL21347414 0.81 MAPT (0.60) TP53PDE4BTNFNOD1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9949980-B2 Drugs to prevent HPV infection WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2018-04-24 US disclosed
US-20150297602-A1 DRUGS TO PREVENT HPV INFECTION NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-10-22 US disclosed
US-9066951-B2 Drugs to treat HPV infection WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2015-06-30 US disclosed
US-20110165220-A1 DRUGS TO PREVENT HPV INFECTION WISCONSIN ALUMNI RESEARCH FOUNDATION 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110165220-A1 DRUGS TO PREVENT HPV INFECTION VHL, PHF13, CDKN1A TP53 5/4885PDE4B 1819/4885TNF 616/4885
US-20150297602-A1 DRUGS TO PREVENT HPV INFECTION VHL, PHF13, CDKN1A TP53 5/4885PDE4B 1819/4885TNF 616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.